Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

DSGNDSGN
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in DESIGN THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 656,584 shares of DSGN (DESIGN THERAPEUTICS INC), worth $9.5M as of 2026-Q2. The position was increased (+30.1% shares). DSGN represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$9.5M

Current Shares

656,584

Total Value Change

+$7.7M

Total Shares Change

+359,455

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
656,584
+30.1%
$9.5M0.0%$14.47
35
2026-Q1
Increased
504,718
+86.5%
$5.4M0.0%$10.00
42
2025-Q4
Increased
270,654
+3.5%
$2.5M0.0%$9.79
27
2025-Q3
Increased
261,445
+9.2%
$2M0.0%$6.85
28
2025-Q2
Decreased
239,459
-10.0%
$806,9770.0%$3.57
0
2025-Q1
Decreased
266,016
-10.5%
$1M0.0%$4.21
0
2024-Q4
New
297,129
-
$1.8M0.0%$6.17
36

Other major holders of DSGN: CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used